Price in deferred time of 15 minutes
|
Last quote
04/17/2024 -
17:43:03
|
Bid
- -
-
|
Bid Volume |
Ask
- -
-
|
Ask Volume |
|---|---|---|---|---|
|
35.54
+0.55
(
+1.57% )
|
-
|
- |
-
|
- |
Analysis date: 16.04.2024
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 15.03.2024.
Interest
Strong
Strong
Strong interest since 16.04.2024.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 23.02.2024 at a price of 35.45.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, at its current price the stock is moderately undervalued.
MT Tech Trend
Negative
Negative
The forty day Medium Term Technical Trend is negative since 15.03.2024. The confirmed Technical Reverse point (Tech Reverse + 1.75%) is
4wk Rel Perf
1.40%
1.40%
The four week relative overperformance versus STOXX600 is 1.40%.
Sensibility
Middle
Middle
Moderate, no change over 1 year.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.68%.
Mkt Cap in $bn
11.05
11.05
With a market capitalization >$8bn, FRESENIUS MED.CARE is considered a large-cap stock.
G/PE Ratio
1.81
1.81
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
9.01
9.01
The estimated PE is for the year 2026.
LT Growth
12.86%
12.86%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
17
17
Over the last seven weeks, an average of 17 analysts provided earnings per share estimates.
Dividend Yield
3.49%
3.49%
The twelve month estimated dividend yield represents 31.48% of earnings forecasts.
Beta
101
101
For 1% of index variation, the stock varies on average by 1.01%.
Correlation
0.31
0.31
Stock movements are strongly independent of index variations.
Value at Risk
5.77
5.77
The value at risk is estimated at EUR 5.77. The risk is therefore 16.50%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002